New ‘Parp inhibitors’ could prevent certain tumours appearing
Breakthrough research could see some genetic cancers neutralised before they take hold and is already being used for people at riskSue Hayward was first diagnosed with ovarian cancer in 2017. Doctors acted swiftly and she was given a hysterectomy followed by sessions of chemotherapy.But her cancer returned within a year. “I carry a mutated version of a gene known as BRCA1 which makes me susceptible to breast and ovarian cancers,” said Hayward, who works at the John Radcliffe Hospital, Oxford. “It runs in families. My mother died of cancer and we assume her mother did as well.”Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - August 14, 2022 Category: Science Authors: Robin McKie Tags: Cancer research Drugs UK news Medical research Science Source Type: news

Survival Boost With Neoadjuvant Chemo-Immunotherapy in NSCLC Survival Boost With Neoadjuvant Chemo-Immunotherapy in NSCLC
Adding neoadjuvant nivolumab to chemotherapy in stage IIIA/IIIB non ¬–small cell lung cancer markedly improves both progression-free and overall survival over neoadjuvant chemotherapy alone.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - August 10, 2022 Category: Allergy & Immunology Tags: Hematology-Oncology News Source Type: news

Why Pelvic Floor Rehabilitation Is Key For Bladder Cancer Patients
Cancer treatment has improved significantly over the past several decades, meaning that more people are living longer after undergoing surgical and medical interventions. This has led to the emergence of an area of cancer care called survivorship, which takes a holistic view of the patient’s well-being and sometimes involves therapies that haven’t always been part of the oncology playbook. In the case of bladder cancer, survivorship and improving quality of life post-surgery sometimes means physical therapy that focuses on improving the function of the pelvic floor. The pelvic floor refers to “the muscles...
Source: TIME: Health - August 10, 2022 Category: Consumer Health News Authors: Elaine K. Howley Tags: Uncategorized Disease freelance healthscienceclimate Source Type: news

Neodjuvant Chemoimmunotherapy Takes Another Step Forward in Stage IIIA-B NSCLC
(MedPage Today) -- VIENNA -- The addition of neoadjuvant nivolumab (Opdivo) to chemotherapy significantly improved outcomes in patients with resectable stage IIIA-B non-small cell lung cancer, according to results from the NADIM II trial. The... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - August 9, 2022 Category: Hematology Source Type: news

Enhertu Approved in the US as the First HER2-Directed Therapy for Patients with HER2-Low Metastatic Breast Cancer
Based on DESTINY-Breast04 results which showed AstraZeneca and Daiichi Sankyo’s Enhertu reduced risk of disease progression or death by 50% and increased overall survival by more than six months versus chemotherapy 6 August 2022 --... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - August 6, 2022 Category: Drugs & Pharmacology Source Type: news

FDA Okays First Targeted Agent for HER2-Low Breast Cancer FDA Okays First Targeted Agent for HER2-Low Breast Cancer
The targeted therapy led to longer progression-free and overall survival compared with chemotherapy.FDA Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 5, 2022 Category: Consumer Health News Tags: Hematology-Oncology News Alert Source Type: news

Indian pharma market grew 14.1% in July, AIOCD report
The fastest growing categories are respiratory which grew at 22.3%, gynaecology - 24%, chemotherapy - 28.4%, urology - 22.5%, ophthalmic - 18.8%, pain - 16.9% and derma - 16.7%. The monsoon related flu-season and rebound of non-emergency surgeries, could have led to the growth of the above segments. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - August 5, 2022 Category: Pharmaceuticals Source Type: news

Hearing Loss, Tinnitus Can Strike Cancer Survivors
THURSDAY, Aug. 4, 2022 -- People who ’ve had chemotherapy to treat a range of common cancers should also have a hearing test. In a new study of 273 cancer survivors, researchers found more than half experienced significant hearing loss even if they... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - August 4, 2022 Category: General Medicine Source Type: news

Study Suggests Relationship Between Stromal Tumors and Mesothelioma
Early identification of peritoneal mesothelioma cancer – when it is most effectively treated – may become more common after a recent study revealed a potential link to gastrointestinal stromal tumors. A single-center retrospective review by the division of surgical oncology at University of California San Diego Moores Cancer Center identified a previously underrecognized, synchronous co-occurrence between the two rare diseases. Annals of Surgical Oncology published the case series in July, which found that one in every 17 patients undergoing resection for gastrointestinal stromal tumors, known as GISTs, also had ...
Source: Asbestos and Mesothelioma News - August 2, 2022 Category: Environmental Health Authors: Fran Mannino Tags: Clinical Trials/Research/Emerging Treatments Peritoneal Source Type: news

Roche ’s subcutaneous formulation of Tecentriq demonstrates positive Phase III results
IMscin001 study showed non-inferior levels of cancer immunotherapyTecentriq in the blood, when injected subcutaneously, compared to intravenous infusion, in people with advanced non-small cell lung cancerAdministered under the skin, the subcutaneous formulation reduces time spent receiving treatment to just minutes, compared with up to an hour for IV infusionData will be submitted to health authorities globally, including the US Food and Drug Administration and European Medicines AgencyBasel, 2 August 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the Phase III IMscin001 study evaluating a subcutaneous form...
Source: Roche Media News - August 2, 2022 Category: Pharmaceuticals Source Type: news

What Are Causes of Childhood Interstital Lung Disease?
Discussion Interstitial lung disease in children (chILD) is less understood than adult interstitial lung disease (ILD) and is rare. Prevalence is ~ 0.13 to 16.2 per 100,000 children under age 17 years. chILD is an general term for respiratory disorders that are heterogeneous, chronic and impair lung function. While some define diffuse parenchymal lung disease (DPLD) separately, the term ILD usually encompases DPLD. chILD has variable definitions and is “usually diagnosed if three of the following features are present: 1) respiratory symptoms (cough, rapid and/or difficult breathing, and exercise intolerance), 2) res...
Source: PediatricEducation.org - August 1, 2022 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

Feeding Dogs Raw Meat Might Exacerbate The Antibiotic Resistance Crisis
In a new study published in the Journal of Antimicrobial Chemotherapy, a team of researchers at the University of Bristol observed that pet dogs who were predominantly on a diet of raw meat were far more likely to poop drug-resistant E.coli bacteria. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - July 31, 2022 Category: Pharmaceuticals Authors: Anuradha Varanasi, Contributor Tags: Healthcare /healthcare Innovation /innovation Source Type: news

Bladder cancer patients who are too frail for chemo offered hope as health chiefs approve drug
In a milestone ruling, UK health chiefs have approved nivolumab for sufferers who are too frail to withstand treatments such as chemotherapy (file photo) (Source: the Mail online | Health)
Source: the Mail online | Health - July 30, 2022 Category: Consumer Health News Source Type: news

'Rogue' Online Pharmacies Are Dispensing Cancer Drugs
(MedPage Today) -- Dozens of illegitimate online pharmacies are selling imatinib, an oral chemotherapy drug for chronic myeloid leukemia (CML), putting patients at risk for toxicities and treatment failures, researchers found. Of 44 online pharmacies... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - July 29, 2022 Category: American Health Source Type: news

Cardiac MRI technique helps measure chemotherapy's effects
A new cardiac MRI technique helps clinicians measure chemotherapy's effectivenes...Read more on AuntMinnie.comRelated Reading: Has cardiac MRI reached its diagnostic potential? Cardiac MRI predicts heart failure risk in cardiomyopathy patients MRI spots myocarditis in young people vaccinated for COVID-19 Myocarditis linked to COVID-19 affects small number of athletes (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - July 29, 2022 Category: Radiology Source Type: news